Interestingly, in patients with DN, the levels of serum TNF-α and its receptor are elevated and are indicative of both renal functional decline and progression to end-stage renal disease [59,60], and inhibiting TNF-α notably alleviated glomerular lesions in murine models of DN [61]. The gene discussed is TNF; the disease is stage 5 chronic kidney disease.